Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

This study has been completed.
Sponsor:
Information provided by:
Guidant Corporation
ClinicalTrials.gov Identifier:
NCT00292539
First received: February 14, 2006
Last updated: April 22, 2009
Last verified: April 2009
  Purpose

This registry is a data collection on patients who are implanted for more than 6 months with a pacemaker. Frequency and distribution of right ventricular pacing, NYHA class and left ventricular ejection fraction shall be documented.


Condition Intervention
Atrial Fibrillation
Bradycardia
Heart Block
Sick Sinus Syndrome
Device: Any pacemaker with right ventricular pacing option

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Preserve Registry: Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

Resource links provided by NLM:


Further study details as provided by Guidant Corporation:

Estimated Enrollment: 600
Study Start Date: February 2006
Study Completion Date: September 2006
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Implanted pacemaker for more than 6 months, VVI/DDD, written consent

Exclusion Criteria:

  • Pacemaker implanted for less than 6 months, no right ventricular pacing possibility (AAI), no consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00292539

Locations
Germany
Kreiskrankenhaus
Viechtach, Germany, 94234
Sponsors and Collaborators
Guidant Corporation
Investigators
Study Director: Sven Treusch, PHD Guidant Corporation
  More Information

No publications provided

Responsible Party: Sven Treusch, Guidant Germany
ClinicalTrials.gov Identifier: NCT00292539     History of Changes
Other Study ID Numbers: Preserve Registry
Study First Received: February 14, 2006
Last Updated: April 22, 2009
Health Authority: Germany: Federal Institute for Drugs and Medical Devices

Keywords provided by Guidant Corporation:
Pacemaker
NYHA class
Ejection fraction
Heart Failure

Additional relevant MeSH terms:
Atrial Fibrillation
Heart Block
Sick Sinus Syndrome
Bradycardia
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes
Arrhythmia, Sinus

ClinicalTrials.gov processed this record on August 28, 2014